Health-care companies rose amid deal activity.
Drug-store chain Walgreens Boots Alliance agreed to buy Summit Health, a chain of doctor's offices and urgent-care centers in the Northeast and Oregon for about $9 billion, including debt.
Drugmaker Viatris agreed to buy two ophthalmology concerns, Oyster Point Pharma and Famy Life Sciences, for a combined $700 million-to-$750 million as it seeks to build an eye-care business.
GSK shares fell sharply after the British drug giant warned of a setback in a late-stage trial for a bone-marrow cancer treatment.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
11-07-22 1724ET
